Research programme: VEGF-targeted vaccines - Protherics
Latest Information Update: 17 Jul 2007
At a glance
- Originator Protherics
- Mechanism of Action Immunostimulants; Vascular endothelial growth factor A inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer metastases
Most Recent Events
- 02 Oct 2001 Preclinical development for Cancer metastases in United Kingdom (unspecified route)